(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid , 98% , 486460-00-8
CAS NO.：486460-00-8
Empirical Formula: C15H18F3NO4
Molecular Weight: 333.31
MDL number: MFCD06659147
EINECS: 691-120-8
| Pack Size | Price | Stock | Quantity |
| 1g | RMB24.00 | In Stock |
|
| 5g | RMB36.00 | In Stock |
|
| 10g | RMB69.60 | In Stock |
|
| 25g | RMB151.20 | In Stock |
|
| 100g | RMB471.20 | In Stock |
|
| 500g | RMB2325.60 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 136-138℃ |
| Boiling point: | 443.1±45.0 °C(Predicted) |
| Density | 1.292±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 4.30±0.10(Predicted) |
| color | White to Off-White |
Description and Uses
Boc-(R) -3-amino-4 -(2,4, 5-trifluorophenyl) butyric acid is an important intermediate for the preparation of sitagliptin. Sitagliptinphosphate is the first dipeptidase -IV(dpp-4) inhibitor approved by FDA in 2006. It is used for the treatment of type II diabetes mellitus. It has obvious hypoglycemic effect when used alone or in combination with metformin and pioglitazone, and it is safe to take, well tolerated, with few adverse reactions.
(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid has been used as a reactant for the preparation of dipeptidyl peptidase-4 (DPP4) inhibitors for the treatment of type 2 diabetes, such as sitagliptin.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P305+P351+P338 |
| HazardClass | IRRITANT |
RELATED PRODUCTS
218608-98-1
269396-59-0
